TrialAntimicrobial agents and chemotherapy2024

Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants.

Michael R Hodges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.